| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/16/2004 | CA2517518A1 Streptococcus pyogenes antigens |
| 09/16/2004 | CA2517375A1 Chicken rna polymerisate i promoter and the use thereof |
| 09/16/2004 | CA2517287A1 Regulation of t cells by lag-3 (cd223) |
| 09/16/2004 | CA2517097A1 Identification of antigen epitopes |
| 09/16/2004 | CA2516098A1 Oxytocin controlled release formulations and methods of using same |
| 09/15/2004 | EP1457500A1 Soluble hybrid prion proteins and their use in the diagnosis, prevention and treatment of transmissible spongiform encephalophathies |
| 09/15/2004 | EP1457499A1 Inhibitors of extracellular Hsp90 |
| 09/15/2004 | EP1457211A1 Recombinant vaccinia virus vaccine |
| 09/15/2004 | EP1456670A2 Methods relating to treatment of atherosclerosis |
| 09/15/2004 | EP1456653A2 Genes encoding g-protein coupled receptors and methods of use therefor |
| 09/15/2004 | EP1456651A2 Self-assembly molecules |
| 09/15/2004 | EP1456650A2 Gfats as modifiers of the p53 pathway and methods of use |
| 09/15/2004 | EP1456403A2 Methods of using 48149, a human aminopeptidase family member |
| 09/15/2004 | EP1456402A2 Means for treatment of atherosclerosis |
| 09/15/2004 | EP1456400A2 Modulating insulin receptor signaling through targeting facl |
| 09/15/2004 | EP1456398A2 Recovery of recombinant human parainfluenza virus type 1 (hpivi) from cdna and use of recombinant hpivi in immunogenic compositions and as vectors to elicit immune responses against piv and other human pathogens |
| 09/15/2004 | EP1456390A2 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines |
| 09/15/2004 | EP1456378A2 Il-17 like molecules and uses thereof |
| 09/15/2004 | EP1456376A2 Novel chimeric rev, tat, and nef antigens |
| 09/15/2004 | EP1456359A2 Preparation of vaccines using photosensitizer and light |
| 09/15/2004 | EP1456347A2 Antibodies that immunospecifically bind to blys |
| 09/15/2004 | EP1456234A2 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 09/15/2004 | EP1456231A2 Streptococcus antigens |
| 09/15/2004 | EP1456230A2 Flavivirus ns1 subunit vaccine |
| 09/15/2004 | EP1456199A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer |
| 09/15/2004 | EP1455858A2 Catheter composition and uses thereof |
| 09/15/2004 | EP1455841A2 Osteopontin-related compositions and methods |
| 09/15/2004 | EP1455829A1 Treating vascular disease by inhibiting myeloid differentiation factor 88 |
| 09/15/2004 | EP1455827A1 Pecam-1 modulation |
| 09/15/2004 | EP1455826A2 Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment of multiple sclerosis |
| 09/15/2004 | EP1455824A2 Lyophilized preparation containing antibodies to the egf receptor |
| 09/15/2004 | EP1455823A2 Anti-t cell immunotoxin fusion protein and its therapeutic use |
| 09/15/2004 | EP1455822A2 Lyophilized monoclonal antibody compositions |
| 09/15/2004 | EP1455821A2 Parathyroid hormone antibodies and related methods |
| 09/15/2004 | EP1455819A1 Individualized anti-cancer antibodies |
| 09/15/2004 | EP1455818A2 Applications of spores |
| 09/15/2004 | EP1455817A2 Staphylococcus aureus exopolysaccharide and process |
| 09/15/2004 | EP1455816A2 Hla class i and ii binding peptides and their uses |
| 09/15/2004 | EP1455812A2 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment |
| 09/15/2004 | EP1455754A2 Pharmaceutical compositions in particulate form |
| 09/15/2004 | EP1455580A2 METHODS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS USING 252, 304, 19870, 14717, 9941, 19310 and 17832 |
| 09/15/2004 | EP1351709B1 Pegylation of linkers improves antitumor activity and reduces toxicity of immunoconjugates |
| 09/15/2004 | EP1187907B1 Method for the preservation of biologically-active material |
| 09/15/2004 | EP1150918B1 Method of manufacturing therapeutic calcium phosphate particles |
| 09/15/2004 | EP1064305B1 Recombinant virus |
| 09/15/2004 | EP1023319B1 Immuno-reactive peptide ctl epitopes of human cytomegalovirus |
| 09/15/2004 | EP1007095B1 CHIMERIC TOXINS COMPRISING GnRH FOR TARGETED THERAPY |
| 09/15/2004 | EP1001806B1 Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation |
| 09/15/2004 | EP0941082B1 New use for 1,3-propanediol derivatives |
| 09/15/2004 | EP0877760B1 Mhc complexes and uses thereof |
| 09/15/2004 | EP0841939B1 Therapeutic agents and autoimmune diseases |
| 09/15/2004 | EP0833919B1 Type f botulinum toxin and use thereof |
| 09/15/2004 | EP0783579B1 Antigenic fragment of the tagA gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
| 09/15/2004 | EP0740553B1 Monoclonal antibodies to antigens expressed by hematopoietic facilitatory cells |
| 09/15/2004 | EP0725653B1 Vaccine compositions |
| 09/15/2004 | EP0678523B1 Recombinant anti-hiv antibody and preparation thereof |
| 09/15/2004 | EP0647275B1 Cloning and expression of gonadotropin-releasing hormone receptor |
| 09/15/2004 | EP0624195B1 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 09/15/2004 | CN1529758A Novel expression vectors and uses thereof |
| 09/15/2004 | CN1529713A Compositions and methods for therapy and diagnosis of ovarian cancer |
| 09/15/2004 | CN1529710A Recombinant protective protein from streptococcus pneumoniae |
| 09/15/2004 | CN1529619A Enhancement of antibody-cytokine fusion protein mediated immune responses by combined treatment with immunocytokine uptake enbancing agents |
| 09/15/2004 | CN1529618A Induction of tolerance |
| 09/15/2004 | CN1529617A Method for treaing autoimmune diseases in subject and in vitro diagnostic assays |
| 09/15/2004 | CN1529616A Vaccine formulation potentiated by combination of DNA and an antigen |
| 09/15/2004 | CN1529615A Method and composition for oral vaccination |
| 09/15/2004 | CN1529613A Method for using nervous thread proteins to treat tumors and other conditions requiring removal of destruction of cells |
| 09/15/2004 | CN1529611A Use of IL-18 inhibitors for treatment or prevention of sepsis |
| 09/15/2004 | CN1528884A Chicken escherichia coli heterotype outer membrane protein cell engineered bacterial strain preparing method |
| 09/15/2004 | CN1528792A Method for extracting red blood cell membrane extract and its use |
| 09/15/2004 | CN1528459A Method for preparing human hydrophobia immune globulin and blood plasma for intravenous injection |
| 09/15/2004 | CN1528458A Heat-resisting lyophilized protectant for chicken newcastle disease, chicken infectious bronchitis (H120, H52) dual lyophilized vaccine and preparing process thereof |
| 09/15/2004 | CN1528457A Heat resisting lyophilized protectant for chicken Marek's disense turkey herpes virus lyophilized vaccine and preparing process thereof |
| 09/15/2004 | CN1528456A Heat resisting lyophilized protectant for chicken infectious bronchitis (H120, H52, Kidney infectious bronchitis W93) lyophilized vaccine and preparing process thereof |
| 09/15/2004 | CN1528455A Heat-resisting lyophilized protectant for swine fever lapinized hyoptoxicity calf testicular cell vaccine and preparing process |
| 09/15/2004 | CN1528454A Foreign duck liver ichthyophthirius active vaccine and preparation method thereof |
| 09/15/2004 | CN1528453A Heat resisting lyophilized protectant for chicken infections Fabianite bursa hypotpxicity (B87) lyophilized vaccine and preparing process thereof |
| 09/15/2004 | CN1528452A Method for preparing broad spectrum genetically engineered nano vaccine for malignant tumour |
| 09/15/2004 | CN1166409C Use of melanoma differentiation associated gene (mda 7) for reversing cancerous phenotype |
| 09/14/2004 | US6790950 Anti-bacterial vaccine compositions |
| 09/14/2004 | US6790947 Polynucleotides encoding macrophage derived chemokine |
| 09/14/2004 | US6790940 For high speed detection |
| 09/14/2004 | US6790939 Anti-PSCA antibodies |
| 09/14/2004 | US6790938 Human autoantibodies and antiidiotypic antibodies against blood platelet membrane proteins |
| 09/14/2004 | US6790826 Human haemopoietic maturation factor |
| 09/14/2004 | US6790656 Galanin receptors (galr2); involved in various neurological and neurodegenerative disorders and treatments |
| 09/14/2004 | US6790649 Phex gene (phosphate regulating gene with homologies to endopeptidases on x chromosome); for treatment of x-linked hypophosphatemia (xlh), a phosphate homeostasis disorder; retardation, bone, renal and metabolism disorders |
| 09/14/2004 | US6790638 Method for selecting tumours expressing HLA-G, sensitive to anticancer treatment and uses |
| 09/14/2004 | US6790631 For diagnosis and therapy of prostate cancer; qualitative analysis |
| 09/14/2004 | US6790630 Glycoproteins; pepsin inhibitors; for detection of heartworm infection in dogs, cats |
| 09/14/2004 | US6790629 Receptor polypeptide for use in the treatment and diagnosis of painful syndromes |
| 09/14/2004 | US6790611 Kit for detecting a respiratory syncytial virus in sample |
| 09/14/2004 | US6790457 Compositions and methods for reducing or preventing fertilization in fish and birds |
| 09/14/2004 | US6790450 Use of coxiella bacteria to treat autoimmune disease |
| 09/14/2004 | US6790449 Methods for producing self-replicating infectious RSV particles comprising recombinant RSV genomes or antigenomes and the N, P, L, and M2 proteins |
| 09/14/2004 | US6790448 Infection therapy |
| 09/14/2004 | US6790446 Campylobacter vaccine |
| 09/14/2004 | US6790445 Preservatives for vaccines |
| 09/14/2004 | US6790443 Administering to the subject a therapeutically effective amount of an agent which inhibits binding of advanced glycation endproducts to any receptor for advanced glycation endproducts |
| 09/14/2004 | US6790440 Administration of a reactive oxygen species (ros) inhibitor or scavenger (a histmine or its salt, ester, prodrug and agonist) and at least one monocyte maturation promoting agent (a cytokine) |